Beyond the Bench: A Century of Experience

The second edition of the Beyond the Bench series features three of Alcami’s longest-tenured employees. Meg, Karen, and Sally have worked at Alcami and its legacy companies over a century, collectively. These women share in common not only a long history with the company, but they are all also great at sharing their knowledge. Please meet Meg, Karen, and Sally. 

Alcami applauds your loyalty and dedication. You are all valued, expert contributors at your sites! Please introduce yourselves and paint a picture of your start with the company .

Topics: Thought Leadership Alcami Voices

Alcami Exhibiting at BIO International Convention 2018

Alcami will be exhibiting at BIO International Convention in Boston, MA, June 4 - 7, 2018

Be sure to stop by Booth 267 to speak with our team!  

Schedule a Meeting with Alcami

Topics: Events

Elevate Product Stewardship and Exceed Your Sustainability Goals

At Alcami, the health and safety of our workers is not taken lightly. Rooted in the foundation of The Alcami Way, safety comes first and is one of our non-negotiables. As a trusted partner and supplier, we can help you achieve your product stewardship and sustainability goals by providing a safe and healthy working environment for our employees.

The globalization of the pharmaceutical industry has led to supply chains that can be extremely complex and difficult to manage. In some cases, the health and safety practices can be vastly different than the current expectations from the public and shareholders. As sustainability intelligence increases, transformative operational strategies are needed to optimize your supply chains and meet your goals.

Topics: Thought Leadership EH&S

Alcami Announces Industry-Leading Analytical Testing Turnaround Time

Durham, NC (USA) – May 8, 2018 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announces the advancement of the drug development process with the company’s new, dramatically-reduced analytical testing turnaround times. Alcami continues to set the industry standard with its analytical testing offering, and through operational excellence, streamlined processes, and technical knowledge and expertise, has reduced timelines by up to 30 percent.

“At Alcami, your timeline is our timeline,” said Alcami Chief Commercial Officer, Syed T. Husain. “We have made efficient, rapid, and reliable turnaround time a priority, as part of our commitment to bring our clients’ products through the clinic and to market first, while delivering the highest level of quality and finest customer experience in the industry.”

Topics: Company News Analytical Testing Development Microbiology Analytical Development

Alcami St. Louis Facility to be Honored by Missouri House of Representatives and City of St. Louis

Durham, NC (USA) – May 3, 2018 – Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biotechnology industries, today announces the Missouri House of Representatives and St. Louis Mayor Lyda Krewson will honor Alcami with a resolution and letter of commendation, recognizing the company’s operational excellence, celebrating its industry-leading accomplishments, and applauding the organization for improving St. Louis citizens’ quality of life.

State Representative Steven Roberts of St. Louis District 77 and City of St. Louis Chief Technology Officer Robert Gaskill-Clemons will issue the proclamation and congratulatory letter Tuesday, May 8, 2018, 2:00 p.m., at an invitation-only customer open house event inside Alcami’s state-of-the-art Center of Excellence for analytical testing.

Topics: Events Company News Alcami in Action Analytical Testing Analytical Development

Case Study: Orphan Drug Product

According to the Food and Drug Administration and the Orphan Drug Designation program,  orphan status is applicable to drugs and biologics which are defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the U.S., or that affect more than 200,000 persons but are not expected to recover the costs of developing and marketing a treatment drug.” Due to the high costs and low demands of the drug product, it is important to efficiently use your API supply during the formulation process. This case study presents how Alcami successfully helped a client overcome an API supply shortage using Quality by Design studies to successfully formulate an orphan drug product. 

Topics: Resource Center Oral Solid Dose API Drug Product Formulations


Name: Michelle Shelton
Alcami Site: Wilmington, NC

How long have you been with Alcami?
I joined Alcami in September 2016.

What is your role? 
I am an Assistant Scientist II. My roles include performing Microbial Limit Tests (MLT), Antimicrobial Effectiveness Test (AET), and growth promotion testing, as well as helping with special studies when the need arises.

What is the most rewarding part of your job?
The people I work with are the most rewarding part of my job. We are dedicated to completing projects accurately and on-time and we support one another daily to make sure that happens.

Topics: Alcami Voices

Top 7 Benefits of the Bruker D8 DISCOVERY HTS™

The D8 DISCOVER HTS combines advanced sample analysis throughput capabilities with great flexibility. This highly innovative system perfectly matches the application requirements of the pharmaceutical industry for crystallization studies, polymorph screening, structure solution, phase identification and crystallite size determination under ambient and non-ambient conditions. With its unparalleled high-throughput screening capability, the D8 DISCOVER HTS provides opportunities for optimization of the development and production of pharmaceuticals 

This state-of-the-art equipment at Alcami's Center of Excellence for Solid State Chemistry in Weert, Netherlands enhances our end-to-end service offering, helping clients meet significant milestones and maintain stability in drug development.

Topics: Solid State

Understanding Pharmaceutical Packaging

For oral solid dose (OSD) pharmaceuticals, decisions regarding the type of packaging used are critical to the success of a product. The best formulated product in the world can fail if it is contained in an inappropriate package. So how does one decide which packaging to use for a product?

First and foremost, the package has to protect the product from damage or degradation. Different barriers can protect from moisture, light, or gases, such as oxygen or carbon dioxide. Blistered products may use cold-formed aluminum to block light completely. Vials, at times, use light protective sleeves for the same purpose. Bottled products may require the use of a coil to keep tablets from breaking during shipment. Alcami works with clients to customize the best package configuration for product protection.

Topics: Thought Leadership Serialization Oral Solid Dose Packaging Pharmaceutical Packaging

ON-DEMAND WEBINAR: Quoting and Sample Submission. Made Simple.

Join Alcami for a webinar to learn more about Alcami OnDemand™.

Introducing a faster and easier way to submit your samples. Our Alcami OnDemand™ portal has been designed to streamline engagement, provide additional insight into our work efforts, and ultimately – unprecedented access, transparency, and visualization into your project work. 

Topics: Webinars Alcami OnDemand Analytical Testing